These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34353770)

  • 1. The prognostic role of baseline
    Can C; Akdeniz N; Kömek H; Gündoğan C; Urakçı Z; Işıkdoğan A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Aug; ():. PubMed ID: 34353770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of baseline
    Can C; Akdeniz N; Kömek H; Gündoğan C; Urakçı Z; Işıkdoğan A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):3-10. PubMed ID: 34991833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Akdeniz N; Kömek H; Küçüköner M; Kaplan MA; Urakçi Z; Oruç Z; Işikdoğan A
    Nucl Med Commun; 2021 Mar; 42(3):315-324. PubMed ID: 33315727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
    Groheux D; Sanna A; Majdoub M; de Cremoux P; Giacchetti S; Teixeira L; Espié M; Merlet P; de Roquancourt A; Visvikis D; Hatt M; Resche-Rigon M; Hindié E
    J Nucl Med; 2015 Jun; 56(6):824-31. PubMed ID: 25883123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
    Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Ability of
    Kiyoto S; Sugawara Y; Hosokawa K; Nishimura R; Yamashita N; Ohsumi S; Mochizuki T
    Asia Ocean J Nucl Med Biol; 2016; 4(1):3-11. PubMed ID: 27904868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Akimoto E; Kadoya T; Kajitani K; Emi A; Shigematsu H; Ohara M; Masumoto N; Okada M
    Clin Breast Cancer; 2018 Feb; 18(1):45-52. PubMed ID: 28993056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of
    Tatar G; Özkul Ö; Alçin G
    Mol Imaging Radionucl Ther; 2022 Jun; 31(2):123-129. PubMed ID: 35770978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
    Koolen BB; Valdés Olmos RA; Wesseling J; Vogel WV; Vincent AD; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Vrancken Peeters MJ
    Ann Surg Oncol; 2013 Jul; 20(7):2227-35. PubMed ID: 23456316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early SUV
    Zhang J; Shi X; Xiao Y; Ma C; Cao G; Liu Y; Li Y
    Quant Imaging Med Surg; 2021 May; 11(5):1680-1691. PubMed ID: 33936956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.
    Buchbender C; Kuemmel S; Hoffmann O; Stahl AR; Kimmig R; Otterbach F; Ladd S; Koeninger A; Forsting M; Bockisch A; Antoch G; Heusner TA
    Acta Radiol; 2012 Jul; 53(6):628-36. PubMed ID: 22761341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer.
    Sengoz T; Arman Karakaya Y; Gültekin A; Yilmaz S; Erdem E; Yapar Taskoylu B; Kesen Z; Yaylali O; Yuksel D
    Eur J Breast Health; 2023 Apr; 19(2):159-165. PubMed ID: 37025574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of
    de Mooij CM; Mitea C; Mottaghy FM; Smidt ML; van Nijnatten TJA
    EJNMMI Res; 2021 Nov; 11(1):116. PubMed ID: 34807395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of
    Kitajima K; Yamano T; Miyoshi Y; Katsuura T; Enoki T; Yamakado K
    Hell J Nucl Med; 2019; 22(1):25-35. PubMed ID: 30843007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
    Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
    J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer.
    Goktas Aydin S; Bilici A; Olmez OF; Oven BB; Acikgoz O; Cakir T; Basim P; Cakir A; Kutlu Y; Hamdard J
    Breast Care (Basel); 2022 Oct; 17(5):470-479. PubMed ID: 36684400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Semiquantitative Parameters Derived from
    Urso L; Evangelista L; Alongi P; Quartuccio N; Cittanti C; Rambaldi I; Ortolan N; Borgia F; Nieri A; Uccelli L; Schirone A; Panareo S; Arnone G; Bartolomei M
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.